Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: Results of the west japan thoracic oncology group trial (WJTOG0401)

Hiroyasu Kaneda, Isamu Okamoto, Hidetoshi Hayashi, Hiroshige Yoshioka, Masaki Miyazaki, Shinzoh Kudoh, Tatsuo Kimura, Takamune Sugiura, Toshiyuki Sawa, Koji Takeda, Yasuo Iwamoto, Miyako Satouchi, Kenji Akita, Hiroshi Saito, Isao Goto, Kazuhiko Shibata, Masahiro Fukuoka, Kazuhiko Nakagawa

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: Results of the west japan thoracic oncology group trial (WJTOG0401)'. Together they form a unique fingerprint.

Medicine & Life Sciences